← Open Payments lookup

MANUK CHULYAN: Open Payments

NPI 1881986826 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$353 in 14 payments from 10 companies in 2025. Trend: 2023 $727 · 2024 $516 · 2025 $353

Food & beverage: $353
CompanyPaymentsAmount
Gilead Sciences, Inc.2$66
Ardelyx, Inc.2$53
AstraZeneca Pharmaceuticals LP2$51
Bayer Healthcare Pharmaceuticals Inc.2$39
Aimmune Therapeutics, Inc.1$34
Lilly USA, LLC1$33
Sumitomo Pharma America, Inc.1$24
Xeris Pharmaceuticals, Inc.1$22
PFIZER INC.1$16
Novo Nordisk Inc1$15

Products named: IBSRELA, BREZTRI, Kerendia, ZENPEP, MOUNJARO, GEMTESA, GVOKE HYPOPEN, NURTEC ODT.

Industry payments across CA — which companies pay providers there.